Increased serum levels of glutamate in adult patients with autism. - Wikidata - awgldk - TriplyDB

Increased serum levels of glutamate in adult patients with autism.

Increased serum levels of glutamate in adult patients with autism.

http://www.wikidata.org/entity/Q34550517

about

The Broad Autism (Endo)Phenotype: Neurostructural and Neurofunctional Correlates in Parents of Individuals with Autism Spectrum Disorders Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism γ-band abnormalities as markers of autism spectrum disorders The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date Mapping autism risk loci using genetic linkage and chromosomal rearrangements.A computational perspective on autism.The Intense World Theory – A Unifying Theory of the Neurobiology of Autism The dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interact Alteration of plasma glutamate and glutamine levels in children with high-functioning autism Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children Transient and steady-state auditory gamma-band responses in first-degree relatives of people with autism spectrum disorder.Low-dose thyroxine attenuates autism-associated adverse effects of fetal alcohol in male offspring's social behavior and hippocampal gene expression.Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.Biochemistry of the cingulate cortex in autism: An MR spectroscopy study.Prefrontal cortex glutamate correlates with mental perspective-taking.Marked elevation of adrenal steroids, especially androgens, in saliva of prepubertal autistic children.RECENT DEVELOPMENTS IN NEUROPATHOLOGY OF AUTISM SPECTRUM DISORDERS.GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders.In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism.Common genetic variation in the GAD1 gene and the entire family of DLX homeobox genes and autism spectrum disorders.Investigation of the serum levels of anterior pituitary hormones in male children with autism.An open-label naturalistic pilot study of acamprosate in youth with autistic disorder.GABA system dysfunction in autism and related disorders: from synapse to symptoms The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis.Blood Glutamate Levels in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI.Overview of Glutamatergic Dysregulation in Central Pathologies.Increased glutamate concentration in the auditory cortex of persons with autism and first-degree relatives: a (1)H-MRS study Early pharmacological treatment of autism: a rationale for developmental treatment.A randomized controlled pilot trial of oral N-acetylcysteine in children with autism.Autism spectrum disorder in children born preterm-role of exposure to perinatal inflammation Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder.Family-Based Association Testing of OCD-associated SNPs of SLC1A1 in an autism sample.Metabolic mapping of deep brain structures and associations with symptomatology in autism spectrum disorders.The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome.mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders.Excitotoxicity in the pathogenesis of autism.

P2860

Q26738652-B35A9A69-2C93-40EC-B62E-7D30CD36ADB0 Q26748761-D03B1840-281E-494A-935C-8E2057222DDE Q26828983-22F371BB-DDDE-4E60-9543-1B8950F08EA4 Q26830642-C5FFE7F2-1229-4F00-B0C6-4C6F6CB299AA Q26998975-2C487AB7-E16C-456E-AF13-9092C21D9DC7 Q27014201-052B07C4-08BC-4C59-A782-3B96EC8934D9 Q27025683-CB167A3D-616D-4896-A335-17980D39429B Q27315912-1BAE29F1-5330-4521-82D9-38D101924943 Q27320751-9BA65369-9490-4BBD-8FC0-233A65103623 Q27500386-594D917F-BB57-4029-81B6-66BF31BF043B Q28388719-E169B541-473A-4F7E-A4DC-3D32C1856538 Q28477358-D1126064-7EC9-4657-A84D-DD902184C55A Q28544817-8C53E44E-8788-4429-9EC3-D4A98CB5083A Q30474736-5AD56335-8116-4064-BF64-A90AAB80AB20 Q30552723-534D2BAC-7736-4E13-9E2D-D14B86106305 Q30593705-02DEAB7E-6FD3-465E-A992-7AB94CBDFE3C Q31015147-CCC50A3A-5E46-44C7-8AF1-EAD700F1F0EC Q33390364-F0CD0507-2BC7-4196-827B-7959E1A5BE83 Q33701158-D8EB76C4-894D-4D69-8C9B-831BC0061157 Q34105312-993F5993-0FBF-4CA2-A67C-362915FF410D Q34568690-6E31AD7E-17D1-4517-8AE2-2144A96EFEC2 Q34777549-CBD98752-F738-4B77-BEF7-921CBEC0100B Q34939651-696EB2B5-C9EB-4B65-9DB1-4587DA6C0F5D Q35549713-70C37E76-795F-4C25-850B-AD46732AA7DF Q35625886-C34AF101-B18A-4E17-A6EE-6889B695528C Q35770888-5695A94A-F56F-4B43-8296-5727B8B0F797 Q36027303-47E21A90-5A21-4986-98AE-D03C4A8AD790 Q36070784-8DE6D6C5-6340-45F5-9FDE-684BEF59D866 Q36123660-D0E64418-9A76-468C-9CF1-94870D85A407 Q36409596-A675D76B-CADC-4CD6-834B-760DE1EBEA48 Q36632136-BBD766B2-B792-4875-92A0-5D5492EB3E44 Q36727667-1C4D8A0B-10D0-435E-98D5-39CA940D38EC Q37022453-85897F07-748A-4386-A7D4-93C13B53A3ED Q37030110-93E9C696-A7DB-458D-ACAB-AA5B5305E7F4 Q37166261-DE1F33AD-D139-42A2-A694-4FA9DDE01D20 Q37208148-AA406AD3-1EF5-4BA4-B5DF-AFB64C522F7D Q37498858-D6C579CC-23F2-4BDA-B4E7-04E9490E8B73 Q37559828-FAE01B21-1523-441D-8475-9B13CFD60FE0 Q38046662-EF2F72A8-352C-4206-91CB-E256DB80CE1F Q38052081-3CC147D1-3E40-4DE1-8BFB-7C76F308A35E

P2860

Increased serum levels of glutamate in adult patients with autism.

http://www.wikidata.org/entity/Q34550517

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Increased serum levels of glutamate in adult patients with autism.

@ast

Increased serum levels of glutamate in adult patients with autism.

@en

Increased serum levels of glutamate in adult patients with autism.

@nl

type

label

Increased serum levels of glutamate in adult patients with autism.

@ast

Increased serum levels of glutamate in adult patients with autism.

@en

Increased serum levels of glutamate in adult patients with autism.

@nl

prefLabel

Increased serum levels of glutamate in adult patients with autism.

@ast

Increased serum levels of glutamate in adult patients with autism.

@en

Increased serum levels of glutamate in adult patients with autism.

@nl

P1433

Q34550517-055FD71B-2DAF-4E89-83C0-56D5FEE8AD6C

P1476

Q34550517-534BE381-362E-4F2B-9849-06E768DE22B2

P2093

Q34550517-0CB81E59-E7FD-44C5-9060-F4C4173BF76F

Q34550517-10BE13A8-4213-4EF5-B64B-F8ECA97BB552

Q34550517-26FE30CF-7090-4CA9-8FD9-B49EC8D90F18

Q34550517-35AB35A2-0F5B-471B-B2CC-2B7B69219B3C

Q34550517-35E6B1A0-2E29-4BE9-B176-BB95AC1134A4

Q34550517-53588EEB-A41A-49D8-A34D-9137C8C6D1BB

Q34550517-798C263E-789D-445F-899E-31BFA4B50A4E

Q34550517-8E7E57A4-71DC-4E0A-BD92-B509AFFF8FC0

Q34550517-953DF24F-33AA-46C3-A948-3F67BE65FCFB

Q34550517-C108D144-F878-48E9-BD4A-95434A756DB6

P304

Q34550517-3041337C-9A9F-4FB5-817D-1B0C4B94CD34

P31

Q34550517-75FC258D-4E91-4792-97C0-9AEDA37A9809

P356

Q34550517-4E7208BF-E96D-4EFD-BA2B-5EC2DE37AD28

P433

Q34550517-7B8A9A98-24B3-4E50-9D70-1AC6E8B85301

P478

Q34550517-896E0D20-554C-4BD3-AA61-0CA61EE125CE

P50

Q34550517-3937D49B-65F9-41F4-BDEB-1D6F2E81CCFB

Q34550517-4147EBA2-17B1-4507-8991-D2C219D9923C

Q34550517-56BEC19A-2556-4438-A572-E6BB59C81207

Q34550517-CE3E9CAA-3A8D-4128-9188-F6F1C008EB3E

P577

Q34550517-C64FEC27-246C-480C-9C7C-D4AA9F024FC6

P698

Q34550517-7B466319-E6A0-43C7-99FA-D142502FF6B5

P921

Q34550517-48E67D11-AE44-45B2-9B96-E92B73A3FB64

P356

J.PNPBP.2006.06.013

P1433

Progress in Neuro-Psychopharmacology & Biological Psychiatry

P1476

Increased serum levels of glutamate in adult patients with autism

@en

P2093

Atsuko Shinohe

http://www.w3.org/2001/XMLSchema#string

Gen-Ichi Sugihara

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Nakamura

http://www.w3.org/2001/XMLSchema#string

Masaomi Iyo

http://www.w3.org/2001/XMLSchema#string

Masatsugu Tsujii

http://www.w3.org/2001/XMLSchema#string

Masayoshi Kawai

http://www.w3.org/2001/XMLSchema#string

Nori Takei

http://www.w3.org/2001/XMLSchema#string

Norio Mori

http://www.w3.org/2001/XMLSchema#string

Shiro Suda

http://www.w3.org/2001/XMLSchema#string

Toshiro Sugiyama

http://www.w3.org/2001/XMLSchema#string

P304

1472-1477

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PNPBP.2006.06.013

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Katsuaki Suzuki

Kenji J. Tsuchiya

Hideo Matsuzaki

P577

2006-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16863675

http://www.w3.org/2001/XMLSchema#string

P921